03-03-2022
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
THursDAy, mArCH 3, 2022
5
EmIlIE FIlOu
The boarding of Uganda Airlines flight
446 from Entebbe to Dubai was
momentarily disrupted at the end of last
year when two of the passengers started
hawking bush crickets in the aisles.
Their fellow travellers couldn't believe
their luck: nsenene are a prized delicacy
in Uganda, but despite November
usually being peak season for the
insects, there had been hardly any
around.
The video from the plane went viral;
there were grumblings about security
breaches, but Uganda Airlines seemed
sympathetic and spotted an
opportunity to turn the crisis into an
opportunity. "We understand that
[nsenene] was not in plenty this season,
hence the excitement. We are
considering adding nsenene to our
menu for regional and international
flights on request," it said in a
statement.
Nsenene are just one of 2,100 known
edible insect species, a quarter of which
are consumed in Africa. Most are highly
prized - often costing more than beef or
chicken by weight - and most are
harvested from the wild.
Catching them is often difficult, they
are seasonal and can be unavailable
when most needed, said Dorte Verner,
lead agriculture economist at the World
Bank's food and agriculture global
practice. They can also be overharvested
or contaminated with
pesticides.
However, with rising food insecurity,
safeguarding this nutritious source of
protein has become critical. "In 2021,
Are farmed insects the next big thing in food industry?
21% of people in countries affected by
fragility, conflict and violence did not
have access to nutritious food," said
Verner. "Also, food production per
capita has been falling since 2014."
Farming the insects is one solution. A
recent report, published by Verner and
World Bank colleagues, on the potential
of hydroponics and insect farming in
Africa, found 849 farms in 10 of the 13
countries they surveyed. While still in
its infancy - most farms were set up in
the last decade - the industry has clear
potential: not only would insects be
available all year, it would create jobs,
help manage food waste, which is used
as feed, and insect manure, or frass,
could create fertilisers.
The World Bank has estimated that
within a year, black soldier fly (BSF)
farming could generate crude protein
worth up to $2.6bn (£1.9bn) and
biofertilisers worth up to $19.4bn. The
process would recycle 200m tonnes of
crop waste.
Although the bulk of existing farms
produce insects for human
consumption, there has been growing
interest in insects as animal feed.
Demand has trebled in the last decade
in Kenya alone, and feed manufacturers
have been increasingly looking for
alternatives to soya and fishmeal, which
are plagued by volatile prices, variable
quality and poor environmental
records.
Nsenene, or bush crickets, are just one of 2,100 known edible insects species, a quarter of which are consumed
in Africa.
Photograph: Eugénie Baccot
Research suggests that animals fed
insect protein, notably BSF, achieved
faster growth rates and better-quality
meat than with soya or fishmeal.
Production costs are relatively stable,
and will go down as operations are
scaled up, said Talash Huijbers, founder
of InsectiPro, one of the largest BSF
farms in Kenya. "With the pandemic,
people are starting to appreciate the
value of local protein production," she
said. Shobhita Soor, head of Legendary
Foods, a palm weevil farm in Ghana,
has seen similar trends. Many of her
customers want to eat "made in Ghana"
products.
Soor's ambition is to "deliver the
nutrition of meat at the price point and
sustainability of plant", a mission that
has led to a relentless search for
efficiency gains. "Last year, we managed
to reduce our costs of production by
40%. If we want to be as ubiquitous as
chicken, it's incumbent on us to do the
R&D to continue to optimise our
production."
She is looking to raise $5m this year to
build her first large-scale plant, while
InsectiPro is planning an $11m
expansion: it has already opened two
more BSF facilities in Kenya and wants
to expand in Uganda and Rwanda.
Only 16 species are farmed in Africa,
but the International Centre of Insect
Physiology and Ecology in Kenya has
been looking at how to raise various
insect species since 2014 and has
trained thousands of would-be
"entopreneurs".
Publications such as the World Bank
report are vital to put insect protein on
the radar of governments - insects do
not appear in any national food
strategy. Other large development
finance institutions, such as the
International Finance Corporation and
the US Agency for International
Development, are also looking into
insect farming. Meanwhile, the World
Bank is planning pilot investments in
South Sudan, Malawi, Kenya and
Zimbabwe.
"From the number of meeting
requests I have received since the
publication of the report, I can tell you
that [people] are really interested," said
Verner.
Affordable analysis
of genomes key to
tackling diseases
ONyANGO NyAmOl
A project equipping
researchers with cheap and
accessible methods for
studying genetic materials of
large collections of bacteria
that cause diseases could be
critical in tackling future
global health challenges,
scientists say.
The 10,000 Salmonella
Genomes Project (10KSG)
could make bacterial genomic
data more accessible in lowand
middle-income
economies, especially in Sub-
Saharan Africa where 80 per
cent of the 77,000 global
annual deaths from nontyphoidal
Salmonella
bloodstream infections occur.
The collaboration of
scientists from 16 countries,
led by the Earlham Institute
and the University of
Liverpool in England, aims to
understand the genetic
makeup of bacterial strains
responsible for Salmonella
bloodstream infections in
Africa and Latin America. This
can increase understanding of
drug resistance and virulence
of the bacteria and help in the
development of vaccines.
"Infectious diseases cause a
huge health and economic
burden on low- and middleincome
countries," says Neil
Hall, director of the Earlham
Institute, a life science
research centre.
"Usually, the most effective
interventions involve public
health measures. However,
public health policy needs to
be well informed by good data
from genomic epidemiological
studies."
In less than a year, scientists
have analysed 10,000
Salmonella genomes from
Africa and Latin America for
as little as US$10 per genome
A project is aiding resource-limited scientists to analyse deadly microbes' genetic
materials .
Photo: Pixaby
or genetic material.
According to researchers,
large-scale bacterial genome
analyses have been possible in
only a few sequencing centres
globally until now and the cost
had been as much as US$100
per genome.
The 10KSG project, Hall
explains, has significantly
reduced the cost and
increased the large-scale study
of genetic materials present in
microbes, enabling many
more scientists to access the
technology worldwide.
Jay Hinton, a professor of
microbial pathogenesis from
the University of Liverpool,
says that for any vaccines to be
effective, there is a need to
know more about the bacteria
causing the disease.
"Our project has provided
the best understanding of the
Salmonella variants
responsible for bloodstream
infections in African countries
including Democratic
Republic of Congo, Gambia,
Mali, Malawi, Kenya, Senegal
and Uganda in recent years -
information that will be
invaluable for evaluating the
impact of the [Salmonella]
vaccine rollout," Hinton
explained.
Damaris Matoke-Muhia, a
molecular biologist at the
Kenya Medical Research
Institute (KEMRI), says that
people trained in sequencing
can train others, in order to
build a qualified workforce.
"Once the facilities are
equipped with sequencing
tools, it will help with
continuous sequencing of
genomes of interest and this
will stop the shipment of
samples that is usually done
due to lack of capacity,
including sequencing SARS-
CoV-2 variants," Matoke-
Muhia tells.
Sultan Mahmud Khan Rony: a
torch bearer for country’s youth
AzHAr AlI, BOGurA
COrrEsPONDENT
The Bogura District Awami
League Publicity and
Publication Secretary Sultan
Mahmud Khan Rony has been
spotlighted as the beacon for
the country's youth. He has
been polite and thoughtful
since his childhood.He is
dedicated to literature, culture
and sports. As per him, in order
to build a strong nation,
intelligence, tolerance and
innovative skills must be
awakened in the youth. Their
leadership will take the country
to the forefront of the world. In
this case, the most important
thing is to curate sports-loving
and culture-oriented minds
among youth. As a result, the
youth get the openness of life,
the formidable attitude of life
struggle, and gain success. By
them this society will become
free of drug abuse, terror, and
militancy.
Father of the Nation
Bangabandhu Sheikh Mujibur
Rahman was a sports minded
and culture oriented person
from his childhood. He became
the leader of the nation at the
time when he first led a sports
team at his early age. In order
for this nation to be known as
the richest nation in the world,
the young people have to be
rony poses for a portrait.
managed properly. The youth
are the shining stars of the
country, nation and society, the
future leaders of the nation. In
order to make them drug free,
they have to develop sports and
culture. The country has
enough youth dependent
energy. It is our responsibility
Photo: TBT
to harness this power. It is with
this thought that Sultan
Mahmud Khan Rony, the
aspiring leader of the youth
society of Bogura, made such
an effort to build the youth
society as enlightened people.
He has continued to support
the neglected, miserable,
disenfranchised and coldblooded
people of the society.
He has distributed food
items, health items and cash
during the Covid-19 pandemic.
In particular, he provided
financial assistance to poor
meritorious students and
sports. In the past, this young
leader was former VP of
Bogura Government Shah
Sultan College Student
Parliament, GS, District
Chhatra League Social Welfare
Secretary, Joint Convener,
General Secretary, Municipal
Awami League Joint Convener
and now District Awami
League Publicity and
Publication Secretary. Besides,
he is currently directly and
indirectly involved with various
social, cultural and educational
institutions including panel
chairman of Bogura district
council, additional general
secretary of district sports
body, president of district
football association, life
member of Bogura Diabetes
Association
He has been able to place
himself in the heart of the mass
by his good behavior.
Especially the entrepreneurial,
sports-loving, literary-minded,
culture-minded people who are
creative thinkers, nurture him
as a source of encouragement.
EsTHEr NAkkAzI
Six African countries are to receive
technology that will enable them to
manufacture COVID-19 vaccines, in an
effort to reduce reliance on producers
outside the continent, the World Health
Organization (WHO) has announced.
Egypt, Kenya, Nigeria, Senegal, South
Africa and Tunisia will get access to the
messenger RNA (mRNA) vaccine
technology along with knowledge
needed to manufacture the vaccines
and support in training scientists, the
WHO said.
The rollout is part of a global initiative
aimed at helping low- and middleincome
countries to access the
technology for producing mRNA
vaccines at scale and to international
standards in order to stem the COVID-
19 pandemic.
MRNA vaccines, used by Pfizer-
BioNTech and Moderna for their shots,
work by instructing cells to produce a
protein which triggers an immune
response to fight viruses when they
enter the body. These two companies
have so far delivered the majority of
their doses to rich countries, leaving
lower-income countries out in the cold.
"No other event like the COVID-19
pandemic has shown that reliance on a
few companies to supply global public
Africa’s COVID-19 fight bolstered with tech transfer
goods is limiting, and dangerous," said
WHO director-general Tedros
Adhanom Ghebreyesu, at a ceremony
on Friday (18 February) hosted by the
European Council, France, South Africa
and the WHO during the European
Union-African Union summit in
Brussels.
The announcement was greeted with
excitement in Africa where only about
12 per cent of the population are fully
vaccinated against COVID-19,
according to data from the Africa
Centres for Disease Control and
Prevention (Africa CDC).
"I'm really pleased to see this
progress," said Africa CDC director
John Nkengasong." The way we fight
the next pandemic will be very
different because the continent would
have been producing diagnostics and
vaccines."
The development follows the creation
of an mRNA vaccine technology
transfer hub run by a WHO consortium
in South Africa, which will share
technical know-how with vaccine
manufacturers in the six countries.
The WHO and partners will train and
help build up the necessary workforce
across the value chain, said Tedros, with
a training hub to be announced in the
coming weeks.
South African president Cyril
Ramaphosa said that enabling Africa to
make its own vaccines meant "mutual
respect and recognition of what we can
all bring to the party, investment in our
economies, infrastructure investment
and, in many ways, giving back to the
continent".
He added: "Organisations such as
COVAX [the initiative for equal access
to COVID-19 vaccines] and Gavi [the
Vaccine Alliance] need to commit to
buying vaccines from our local
manufacturers. They need to buy them
from the locally produced hubs once
they get going."
Ramaphosa also called upon
European countries to approve an
intellectual property waiver on COVID
technology, which has been before the
World Trade Organization for over a
year.
"Governments that are really serious
about ensuring that the world has
access to vaccines should ensure that we
approve the TRIPS [Trade-Related
Aspects of Intellectual Property Rights]
waiver as we've put it forward," he
added.
Ultimately the mRNA tech transfer
hub will promote access to vaccines for
everyone, strengthen health security
and promote self-reliance for the future,
according to the WHO. It says the
technology can also be used for insulin
to treat diabetes, cancer medicines and,
potentially, vaccines for diseases such
as malaria, tuberculosis and HIV.
"Diversifying mRNA vaccine
manufacturing capacity to low- and
middle-income countries should be a
global health priority," said Doctors
Without Borders (MSF), in response to
the WHO announcement.
"More regions producing mRNA
vaccines as essential preparedness
against infectious diseases could bolster
the response not only to COVID-19 and
future infectious diseases, but also
potentially to existing ones such as
malaria, tuberculosis and HIV."
German biotechnology company
BioNTech announced on Wednesday
(16 February) that it will create
accessible technology for mRNA
manufacturing in Rwanda and Senegal
in 2022 - with a fill-and-finish
collaboration in Ghana. Fill-and-finish
is the process of filling vials with vaccine
and finishing the process of packaging
the medicine for distribution.
Earlier this month Afrigen, which is
part of the WHO's South Africa
consortium, announced it had
developed its own version of an mRNA
shot, based on publicly available data on
the composition of the Moderna
vaccine, to be tested in the coming
months.
Patrick Tippoo, executive director of
the Africa Vaccine Manufacturing
Initiative (AVMI), told SciDev.Net that
while access to technology in terms of
written recipes and permission to use
them was important, Africa needed to
be confident of securing and sustaining
a market for its products.
The WHO has announced that six African countries are to receive technology
to enable them to manufacture COVID-19 vaccines. Photo: Hakan German